December 17, 2024 · Form 4 insider transaction
Delaet Ingrid sold 1,091 shares of Neurocrine Biosciences, Inc. at $135.00 per share, a transaction worth $147.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023.